Navigation Links
Finland invests €1.85 million in pan-European infrastructure for biomedical research
Date:2/3/2010

collecting biobank samples and associated clinical as well as molecular profile information.

Professor Rudi Balling, director of the Luxembourg Centre for Systems Biomedicine and the coordinator of EATRIS, says "We are delighted with Finland taking the lead for a significant national commitment towards a European translational research infrastructure. This reflects the excellence of biomedical research in Finland and the recognition that infrastructure is key for Europe to stay competitive".

EMBL-EBI Director and ELIXIR coordinator Professor Janet Thornton, adds "Finland's active participation in developing ELIXIR is excellent news. The close interaction between the biomedical research infrastructures in Finland will help Europe to develop a fully integrated approach to handling heterogeneous data and exploiting it for translational research ".

Professor Kurt Zatloukal from Medical University of Graz and coordinator of BBMRI who has actively worked towards coordination of BMS ESFRIs at EU level further comments "We are delighted to see that coordination of BMS infrastructures also takes place at the national level".

Ms Eeva Ikonen, senior science advisor at the Academy of Finland, comments "Finland has made substantial contributions towards construction and upgrading of national infrastructures through Biocenter Finland. This current funding decision aims at establishing a firm Finnish role on in the development and implementation of BBMRI, EATRIS and ELIXIR. Our approach could hopefully also serve as a model for tighter integration between other European research infrastructures".

Consortium members have also signed a memorandum of understanding.


'/>"/>

Contact: Dr. Olli Kallioniemi
olli.kallioniemi@helsinki.fi
358-919-125-731
University of Helsinki
Source:Eurekalert

Page: 1 2

Related biology news :

1. University of Plymouth invests in dental research
2. NIGMS invests in scientific Grand Opportunities with Recovery Act funds
3. Texas invests record $3.5 million in startup cofounded by UTs Mauro Ferrari
4. NIEHS invests $21.25 million to find environmental causes of Parkinsons disease
5. The AGA Foundation invests in gastroenterologys future
6. Helios Education Foundation invests $6.5 million
7. NOAA invests $3 million for unmanned aircraft system testing
8. NIBIB invests in quantum research
9. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
10. LSTM begins £0.5 million malaria study in Burkina Faso
11. Scripps Research scientists create new way to screen libraries of 10 million or more compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... 26, 2015 ATL Technology, LLC, a top provider ... in single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Jose, Costa Rica ). This acquisition will ... with ATL Technology,s existing facility in Costa ...
(Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
(Date:6/24/2015)... , June 24, 2015  Synaptics Inc. ... human interface solutions, today announced that Sharp has ... provide secure authentication for its latest flagship smartphone ... more than 200 million shipments of its fingerprint ... reinforces Synaptics, strength, scalability and leadership in the ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... Center have identified a variation in a particular gene ... years, scientists have known that the devastating, early-onset form ... about the gene(s) responsible until now. The results are ... Genetics . In a previous study, a region ...
... BioScience includes the following research articles: ... Advancing Understanding. Heather L. Sanders and Sarah ... genes and epigenetic phenomena that regulate the development ... that are becoming available for the study of ...
... complex genetic signature associated with Alzheimer,s disease, the ... the elderly. The research, published by Cell Press ... Journal of Human Genetics , uses a powerful, ... this devastating neurodegenerative disorder. Previous research ...
Cached Biology News:Genetic variation may lead to early cardiovascular disease 2BioScience tip sheet, January 2009 2Scientists make strides toward defining genetic signature of Alzheimer's disease 2
(Date:7/1/2015)... AURORA, Colo. and BANGALORE, India ... a global genomic profiling company that uses next generation ... appointment of Scott A. Storrer as chief ... and CEO, he will be responsible for all strategy, ... Vijay Chandru , who has served as Strand,s chairman ...
(Date:7/1/2015)... InferMed , s ... will augment Elsevier ... olutions suite   Elsevier , a world-leading ... announced today the acquisition of  InferMed , a ... InferMed,s Arezzo technology supports clinicians in choosing the most ...
(Date:6/30/2015)... ... 2015 , ... Students and faculty from Beijing City University ... “Integrative Biotechnology,” an applied biotechnology course team-taught by faculty members from both institutions. ... from both universities and is taught on both continents. , “Our alliance with ...
(Date:6/30/2015)... , June 30, 2015  Today, Americord Registry, one of ... Andrew Horne , a partner at Kirkland & Ellis ... Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We ... Advisory Board," says Martin Smithmyer , CEO of Americord. ... legal career that will assist Americord,s growth and vision." ...
Breaking Biology Technology:Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2Americord Registry Announces Andrew Horne as Advisory Board Member 2
... Ltd. (Amex:,SVA), a vaccine-focused biotech company in China, ... two upcoming investor conferences, including the,Oppenheimer 19th Annual ... Suisse Asian Healthcare Conference in Beijing, China., ... to present on,Tuesday, November 4, 2008 at 3:20 ...
... 29 Osteotech, Inc.,(Nasdaq: OSTE ), a ... for,regenerative healing, announced today that it has received ... Administration ("FDA") for its next,generation grafting material. Osteotech ... graft substitute, and as a bone void filler, ...
... Oct. 29 Genomic Health,Inc. (Nasdaq: GHDX ) ... and webcast on Wednesday, November 5, 2008 at 4:30 ... results. The call and webcast,will follow the release of ... Call Details, To access the live conference call ...
Cached Biology Technology:Sinovac to Participate in Two Upcoming Investor Conferences 2Osteotech Receives FDA Clearance for its Next Generation Grafting Material 2Genomic Health to Announce Third Quarter 2008 Financial Results and Host Conference Call on Wednesday, November 5, 2008 2
UGT1A6 (D-20)...
...
... The T2-02 diaphragm pump features T Squareds ... achieves remarkable performance and efficiency. With the ... range, T2-02 is ideal for use in ... ultra-compact size, long life, and high efficiency. ...
Normal Hamster Serum...
Biology Products: